The market and small-cap stocks have had a terrific month; many of our recommendations have pushed nicely higher in recent weeks, and while some profit taking is always a possibility, the strong fundamental backdrop for our stocks is bullish. This month’s recommendation comes from the emerging field of biocatalysts, where the aim is to develop so-called super enzymes that can make chemical reactions (used in the manufacture of certain drugs, for instance) drastically more efficient. The company is a leader in this young industry, and has already established deals with many big firms. It’s a big idea, and we think you’ll like the story inside.
